# Insulin Aspart

NDC: 50090-4956
Generic name: insulin aspart
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20030122

FDA application: BLA020986

## Active ingredients

- INSULIN ASPART: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-4956"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-4956
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3e4c46e-5211-4f05-b7ab-1e9ad270876b